The relationship between Helicobacter pylori infection and gastric adenocarcinoma in Northern Iran

Oncology Research

Volumn 18, Issue 7, 2010, Pages 323-328

  Salehi, Zivar ^a   Mollasalehi, Hamidreza ^a   Jelodar, Mohammad Halimi ^a   Kazemi, Masoud ^a   Zahmatkesh, Rasoul ^a  

^a UNIVERSITY OF GUILAN   (Iran)

Author keywords

cagA; Gastric adenocarcinoma; Helicobacter pylori

Indexed keywords

CAGA PROTEIN;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DYSPEPSIA; FEMALE; GENE SEQUENCE; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE CHARACTERIZED AMPLIFIED REGION; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH CARCINOGENESIS; STOMACH MUCOSA; STOMACH ULCER;

EID: 77950563497     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504010X12626118079985     Document Type: Article

References (38)

1. Blaser, M. J. Helicobacter pylori: Microbiology of a "slow" bacterial infection. Trends Microbiol. 1:255-259; 1993.
2. Warren, J. R.; Marshall, B. J. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1:1273-1275; 1983.
3. Soll, A. H. Pathogenesis of peptic ulcer and implications for therapy. N. Engl. J. Med. 322:909-916; 1990.
4. Stemmermann, G. N.; Marcus, E. B.; Buist, A. S.; MacLean, C. J. Relative impact of smoking and reduced pulmonary function on peptic ulcer risk. Gastroenterology 96:1419-1424; 1989.
5. Kato, I.; Nomura, A. M. Y.; Stemmermann, G. N.; Chyou, P. H. A prospective study of gastric and duodenal ulcer and its relation to smoking, alcohol, and diet. Am. J. Epidemiol. 135:521-530; 1992.
6. Monack, D. M.; Mueller, A.; Falkow, S. Persistent bacterial infections: The interface of the pathogen and the host immune system. Nat. Rev. Microbiol. 2:747-765; 2004.
7. Blaser, M. J. Hypothesis: The changing relationships of Helicobacter pylori and humans: Implications for health and disease. J. Infect. Dis. 179:1523-1530; 1999.
8. Odenbreit, S.; Puls, J.; Sedlmaier, B.; Gerland, E.; Fischer, W.; Haas, R. Translocation of Helicobacter pylori: CagA into gastric epithelial cells by type IV secretion. Science 287:1497-1500; 2000.
9. Peek, R. M.; Miller, G. G.; Tham, K. T.; Perez-Perez, G. I.; Zhao, X.; Atherton, J. C.; et al. Heightened inflammatory response and cytokine expression to cagA+ Helicobacter pylori strains. Lab. Invest. 73:760-770; 1995.
10. Crabtree, J. E.; Taylor, J. D.; Wyatt, J. I.; Heatley, R. V.; Shallcross, T. M.; Tompkins, D. S.; et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 338:332-335; 1991.
11. Karita, M.; Blaser, M. J. Acid tolerance response in Helicobacter pylori and differences between cagA+ and cagA-strains. J. Infect. Dis. 178:213-219; 1998.
12. Blaser, M. J. Ecology of Helicobacter pylori in the human stomach. J. Clin. Invest. 100:759-762; 1997.
13. IARC. Schistosomes, liver flukes and Helicobacter pylori. In: IARC monographs on the evaluation of carcinogenic risks to humans, vol.61. Geneva: WHO Press; 1994.
14. Blaser, M. J.; Perez-Perez, G. I.; Kleanthous, H.; Cover, T. L.; Peek, R. M.; Chyou, P. H.; et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 15:2111-2115; 1995.
15. Kuipers, E. J.; Perez-Perez, G. I.; Meuwissen, S. G.; Blaser, M. J. Helicobacter pylori and atrophic gastritis: Importance of the cagA status. J. Natl. Cancer Inst. 87:1777-1780; 1995.
16. Parkin, D. M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118:3030-3044; 2002.
17. Correa, P.; Haenszel, W.; Cuello, C.; Tannenbaum, S.; Archer, M. A model for gastric cancer epidemiology. Lancet 2:58-60; 1975.
18. Hatakeyama, M.; Higashi, H. Helicobacter pylori CagA: A new paradigm for bacterial carcinogenesis. Cancer Sci. 96:835-843; 2005.
19. Gray, S. F.; Wyatt, J. I.; Rathbone, B. J. Simplified techniques for identifying Campylobacter pyloridis. J. Clin. Pathol. 39:1279-1280; 1986.
20. Laurén, P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Pathol. Microbiol. Scand. 64:31-49; 1965.
21. Scholte, G. H.; van Doorn, L. J.; Quint, W. G.; Lindeman, J. Polymerase chain reaction for the detection of Helicobacter pylori in formaldehyde- sublimate fixed, paraffin-embedded gastric biopsies. Diagn. Mol. Pathol. 6:238-243; 1997.
22. Bickley, J.; Owen, R. J.; Fraser, A. G.; Pounder, R. E. Evaluation of the polymerase chain reaction for detecting the urease C gene of Helicobacter pylori in gastric biopsy samples and dental plaque. J. Med. Microbiol. 39:338-344; 1997.
23. Ernst, P. B.; Peura, D. A.; Crowe, S. E. The translation of Helicobacter pylori basic research to patient care. Gastroenterology 130:188-206; 2006.
24. Yamaguchi, N.; Kakizoe, T. Synergistic interaction between Helicobacter pylori gastritis and diet in gastric cancer. Lancet Oncol. 2:84-94; 2001.
25. Yazdannbod, A.; Arshi, S.; Derakhshan, M. H.; Sadjadi, A. R.; Malekzadeh, R. Gastric cardia cancer; the most common type of upper gastrointestinal cancer in Ardabil, Iran: An endoscopy clinic experience. Arch. Irn. Med. 4:76-79; 2001.
26. Salehi, Z.; Jelodar, M. H.; Rassa, M.; Ahaki, M.; Mollasalehi, H.; Mashayekhi, F. Helicobacter pylori cagA status and peptic ulcer disease in Iran. Dig. Dis. Sci. 54:608-613; 2009.
27. Matysiak-Budnik, T.; Mégraud, F. Helicobacter pylori infection and gastric cancer. Eur. J. Cancer 42:708-716; 2006..
28. Mégraud, F.; Lehours, P. Helicobacter pylori and gastric cancer prevention is possible. Cancer Detect. Prev. 28:392-398; 2004.
29. Baldari, C. T.; Lanzavecchia, A.; Telford, J. L. Immune subversion by Helicobacter pylori. Trends Immunol. 26:199-207; 2005.
30. Höcker, M.; Hohenberger, P. Helicobacter pylori virulence factors - one part of a big picture. Lancet 362:1231-1233; 2003.
31. Meimarakis, G.; Winter, H.; Assmann, I.; Kopp, R.; Lehn, N.; Kist, M.; et al. Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: A prospective study. Lancet Oncol. 7:211-222; 2006.
32. Trajkov, D.; Stardelova, K.; Dimitrova, M.; Mishevski, J.; Serafimoski, V. Helicobacter pylori and gastric carcinoma. Prilozi 28:39-46; 2007.
33. Huang, J. Q.; Zheng, G. F.; Sumanac, K.; Irvine, E. J.; Hunt, R. H. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 125:1636-1644; 2003.
34. Azuma, T.; Yamakawa, A.; Yamazaki, S.; Ohtani, M.; Ito, Y.; Muramatsu, A.; et al. Distinct diversity of the cag pathogenicity island among Helicobacter pylori strains in Japan. J. Clin. Microbiol. 42:2508-2517; 2004.
35. Louw, J. A.; Kidd, M. S. G.; Kummer, A. F.; Taylor, K.; Kotze, U.; Hanslo, D. The relationship between Helicobacter pylori infection, the virulence genotypes of the infecting strain and gastric cancer in the African setting. Helicobacter 6:268-273; 2001.
36. Parsonnet, J.; Friedman, G. D.; Orentreich, N.; Vogelman, H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40:297-301; 1997.
37. Mitchell, H. M.; Hazell, S. L.; Li, Y. Y.; Hu, P. J. Serological response to specific Helicobacter pylori antigens: Antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am. J. Gastroenterol. 91:1785-1788; 1996.
38. Mehlke, S.; Kibler, K.; Kim, J. G.; Figura, N.; Small, S. M.; Graham, D. Y.; et al. Allelic variation in the CagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am. J. Gastroenterol. 91:1322-1325; 1996.